gga03010 | Ribosome* | 16 | 7.74 | < 0.0001 | RPL22L1, RPL36, RPLP1, RPS15, RPS21, MRPL32, MRPS10, RPS7, MRPL35, RPS24, RPL35A, RPL37, RPS28, RPL27A, RPL29, RPL38 |
gga00190 | Oxidative phosphorylation* | 7 | 3.53 | 0.003 | NDUFB7, ATP5J, NDUFV3, ATP5H, NDUFB1, COX17, UQCR10 |
gga03320 | PPAR signaling pathway* | 4 | 3.93 | 0.018 | SCD, LPL, FABP6, FABP2 |
gga00310 | Lysine degradation | 3 | 3.40 | 0.057 | KMT2A, ASH1L, KMT2D |
gga04933 | AGE-RAGE signaling pathway in diabetic complications | 4 | 2.65 | 0.063 | FN1, COL4A2, NFATC1, PLCE1 |
gga04010 | MAPK signaling pathway | 7 | 1.84 | 0.085 | CACNA1B, ELK4, NFATC1, CACNA2D2, CACNA1G, PDGFRB, PTPRR |
gga04260 | Cardiac muscle contraction | 3 | 2.85 | 0.087 | ACTC1, CACNA2D2, UQCR10 |
gga04810 | Regulation of actin cytoskeleton | 6 | 1.89 | 0.096 | ITGA1, FN1, SSH2, WASF1, ARHGEF4, PDGFRB |
gga00260 | Glycine, serine and threonine metabolism | 2 | 3.19 | 0.129 | GCSH, PHGDH |
gga04514 | Cell adhesion molecules (CAMs) | 4 | 2.05 | 0.13 | SDC3, NFASC, NLGN3, SIGLEC1 |